Open AccessComposition ofLycium barbarumpolysaccharides and their apoptosis-inducing effect on human hepatoma SMMC-7721 cells
Author(s) -
Qian Zhang,
Xiaoling Lv,
Tao Wu,
Qian Ma,
Anguo Teng,
Ying Zhang
Publication year - 2015
Publication title -
food and nutrition research/food and nutrition research. supplement
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 37
eISSN - 1654-6628
pISSN - 1654-661X
DOI - 10.3402/fnr.v59.28696
Subject(s) - fucose , rhamnose , galactose , arabinose , monosaccharide , mannose , uronic acid , polysaccharide , chemistry , xylose , lycium , apoptosis , galactosamine , biochemistry , medicine , pathology , alternative medicine , fermentation
Background Lycium barbarum polysaccharide (LBP) is a natural functional component that has a variety of biological activities. The molecular structures and apoptosis-inducing activities on human hepatoma SMMC-7721 cells of two LBP fractions, LBP-d and LBP-e, were investigated. Results The results showed that LBP-d and LBP-e both consist of protein, uronic acid, and neutral sugars in different proportions. The structure of LBP was characterized by gas chromatography, periodate oxidation, and Smith degradation. LBP-d was composed of eight kinds of monosaccharides (fucose, ribose, rhamnose, arabinose, xylose, mannose, galactose, and glucose), while LBP-e was composed of six kinds of monosaccharides (fucose, rhamnose, arabinose, mannose, galactose, and glucose). LBP-d and LBP-e blocked SMMC-7721 cells at the G0/G1 and S phases with an inhibition ratio of 26.70 and 45.13%, respectively, and enhanced the concentration of Ca 2+ in the cytoplasm of SMMC-7721. Conclusion The contents of protein, uronic acid, and galactose in LBP-e were much higher than those in LBP-d, which might responsible for their different bioactivities. The results showed that LBP can be provided as a potential chemotherapeutic agent drug to treat cancer.